![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C12N 9/96 | |
A61K 38/48 | |||
A61K 38/36 |
(11) | Patento numeris | 2591099 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 11738538.5 |
Europos patento paraiškos padavimo data | 2011-07-11 | |
(97) | Europos patento paraiškos paskelbimo data | 2013-05-15 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2011/043597 |
Data | 2011-07-11 |
(87) | Numeris | WO 2012/006633 |
Data | 2012-01-12 |
(30) | Numeris | Data | Šalis |
201161442055 P | 2011-02-11 | US | |
201161467880 P | 2011-03-25 | US | |
363183 P | 2010-07-09 | US | |
201161491762 P | 2011-05-31 | US | |
201161442150 P | 2011-02-11 | US | |
363186 P | 2010-07-09 | US | |
201161442029 P | 2011-02-11 | US |
(72) |
SALAS, Joe, US
PETERS, Robert, US
BITONTI, Alan, US
|
(73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
(54) | CHIMERIC CLOTTING FACTORS |
CHIMERIC CLOTTING FACTORS |